R. Izu

539 total citations
33 papers, 351 citations indexed

About

R. Izu is a scholar working on Dermatology, Immunology and Oncology. According to data from OpenAlex, R. Izu has authored 33 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Dermatology, 12 papers in Immunology and 9 papers in Oncology. Recurrent topics in R. Izu's work include Dermatology and Skin Diseases (7 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Drug-Induced Adverse Reactions (5 papers). R. Izu is often cited by papers focused on Dermatology and Skin Diseases (7 papers), Cutaneous lymphoproliferative disorders research (7 papers) and Drug-Induced Adverse Reactions (5 papers). R. Izu collaborates with scholars based in Spain, United States and Germany. R. Izu's co-authors include J.L. Díaz-Pérez, Jesús Gardeazábal, María Dolores Boyano, Aintzane Asumendi, Gorka Pérez‐Yarza, Aintzane Apraiz, Jesús M. Cortés, J.M. Hernánz, M. Sánchez‐Regaña and Fernando Gallardo and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Cancer.

In The Last Decade

R. Izu

32 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Izu Spain 11 173 107 89 73 69 33 351
Deepak Balak Netherlands 13 152 0.9× 241 2.3× 80 0.9× 78 1.1× 40 0.6× 30 435
Gianluca Avallone Italy 13 201 1.2× 181 1.7× 70 0.8× 71 1.0× 105 1.5× 52 414
Luca Mastorino Italy 15 334 1.9× 275 2.6× 71 0.8× 70 1.0× 76 1.1× 77 547
Ya‐Chu Tsai Taiwan 10 182 1.1× 229 2.1× 42 0.5× 40 0.5× 25 0.4× 16 376
C Popescu Romania 9 139 0.8× 42 0.4× 27 0.3× 59 0.8× 79 1.1× 17 330
Melissa Magliocco United States 5 166 1.0× 346 3.2× 32 0.4× 49 0.7× 72 1.0× 9 466
Jennifer W. Gould United States 6 219 1.3× 60 0.6× 60 0.7× 32 0.4× 30 0.4× 7 341
So Yeon Paek United States 10 186 1.1× 188 1.8× 65 0.7× 46 0.6× 48 0.7× 27 385
Shivani B. Kaushik United States 9 407 2.4× 490 4.6× 98 1.1× 111 1.5× 48 0.7× 10 786
R.E. Schopf Germany 9 144 0.8× 332 3.1× 46 0.5× 31 0.4× 48 0.7× 17 585

Countries citing papers authored by R. Izu

Since Specialization
Citations

This map shows the geographic impact of R. Izu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Izu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Izu more than expected).

Fields of papers citing papers by R. Izu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Izu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Izu. The network helps show where R. Izu may publish in the future.

Co-authorship network of co-authors of R. Izu

This figure shows the co-authorship network connecting the top 25 collaborators of R. Izu. A scholar is included among the top collaborators of R. Izu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Izu. R. Izu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gracia‐Cazaña, Tamara, et al.. (2024). Real-world outcomes in patients with malignancy and moderate-to-severe psoriasis treated with guselkumab. JAAD International. 16. 66–71. 2 indexed citations
4.
Gardeazábal, Jesús, R. Izu, Estíbaliz Garrote, et al.. (2023). Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients. Cancers. 15(7). 2174–2174. 13 indexed citations
5.
Malaina, Iker, Luis Martínez, Aintzane Asumendi, et al.. (2023). Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. International Journal of Molecular Sciences. 24(10). 9024–9024. 2 indexed citations
6.
Penas, Cristina, Aintzane Apraiz, Javier Rasero, et al.. (2023). Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression. Scientific Reports. 13(1). 9561–9561. 4 indexed citations
7.
Izagirre, Neskuts, Conrado Martínez‐Cadenas, Manuel Martín González, et al.. (2022). Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis. Life. 12(12). 2004–2004. 5 indexed citations
8.
Rivera, R., Antonio Martorell, Ángel L. López, et al.. (2020). Maintenance of response following discontinuation of guselkumab and secukinumab in Spanish patients who participated in the ECLIPSE study. Journal of the European Academy of Dermatology and Venereology. 35(1). e65–e67. 11 indexed citations
9.
Cabello, Irene, Pedro Alía, Xavier Pintó, et al.. (2018). Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene. JAMA Dermatology. 154(12). 1424–1424. 6 indexed citations
10.
Carrascosa, J.M., et al.. (2015). Recomendaciones de expertos para el tratamiento de la psoriasis en situaciones especiales. Actas Dermo-Sifiliográficas. 106(4). 292–309. 9 indexed citations
11.
Hernánz, J.M., et al.. (2012). Clinical and Therapeutic Evaluation of Patients With Moderate to Severe Psoriasis in Spain: The Secuence Study. Actas Dermo-Sifiliográficas. 103(10). 897–904. 10 indexed citations
12.
Hernánz, J.M., et al.. (2012). Evaluación clínica y terapéutica de los pacientes con psoriasis moderada o grave en España. Estudio Secuence. Actas Dermo-Sifiliográficas. 103(10). 897–904. 12 indexed citations
13.
Izu, R., et al.. (2008). Cutaneous Reactive Angiomatosis Associated With Chronic Lymphoid Leukemia. American Journal of Dermatopathology. 30(6). 604–607. 3 indexed citations
14.
Pérez‐Yarza, Gorka, María Dolores Boyano, Aintzane Apraiz, et al.. (2008). Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. British Journal of Dermatology. 160(3). 519–526. 49 indexed citations
15.
Izu, R., et al.. (2005). Tratamiento de linfomas cutáneos de células T con bexaroteno. Actas Dermo-Sifiliográficas. 96(10). 669–673. 7 indexed citations
16.
Izu, R., et al.. (1994). A case of the elephant man phenotype with giant rhinophyma and benign symmetric lipomatosis. Clinical and Experimental Dermatology. 19(6). 531–533. 8 indexed citations
17.
Izu, R., et al.. (1994). Allergic contact cheilitis from mandelic acid. Contact Dermatitis. 31(2). 133–134. 5 indexed citations
18.
Izu, R., et al.. (1994). Allergic contact dermatitis from Reflex® spray. Contact Dermatitis. 30(1). 52–53. 18 indexed citations
19.
Gardeazábal, Jesús, et al.. (1993). Allergic contact dermatitis due to plant extracts in a multisensitized patient. Contact Dermatitis. 28(3). 186–187. 4 indexed citations
20.
Izu, R., et al.. (1993). Edematous allergic contact cheilitis from a toothpaste. Contact Dermatitis. 28(1). 42–42. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Deepak Balak Breakdown of academic impact, for papers by Gianluca Avallone Breakdown of academic impact, for papers by Luca Mastorino Breakdown of academic impact, for papers by Ya‐Chu Tsai Breakdown of academic impact, for papers by C Popescu Breakdown of academic impact, for papers by Melissa Magliocco Breakdown of academic impact, for papers by Jennifer W. Gould Breakdown of academic impact, for papers by So Yeon Paek Breakdown of academic impact, for papers by Shivani B. Kaushik Breakdown of academic impact, for papers by R.E. Schopf
Rankless by CCL
2026